SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-21-065971
Filing Date
2021-03-03
Accepted
2021-03-02 19:02:59
Documents
4
Effectiveness Date
2021-03-03

Document Format Files

Seq Description Document Type Size
1 S-8 POS d138264ds8pos.htm S-8 POS 33904
2 EX-5.1 d138264dex51.htm EX-5.1 11337
3 GRAPHIC g138264dsp6logo.jpg GRAPHIC 3160
4 GRAPHIC g138264dsp7logo.jpg GRAPHIC 1855
  Complete submission text file 0001193125-21-065971.txt   53518
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-253776 | Film No.: 21706072
SIC: 2834 Pharmaceutical Preparations